214450.KQ
PharmaResearch Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 381,000.00
−2.93%Margins
Gross margin
75.4%
EBITDA margin
32.7%
EBIT margin
39.1%
Net margin
30.8%
FCF margin
22.8%
24.6%
Return on equity
16.8%
Return on assets
24.2%
Return on invested capital
0.55x
Asset turnover
KRW 173.4B
Cash from operations
KRW 55.9K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026